{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:19:47Z","timestamp":1793996387340,"version":"4.8.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["M22030"],"award-info":[{"award-number":["M22030"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005198","name":"Chinese Foundation for Hepatitis Prevention and Control","doi-asserted-by":"publisher","award":["TQGB20190050"],"award-info":[{"award-number":["TQGB20190050"]}],"id":[{"id":"10.13039\/501100005198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005198","name":"Chinese Foundation for Hepatitis Prevention and Control","doi-asserted-by":"publisher","award":["2020033"],"award-info":[{"award-number":["2020033"]}],"id":[{"id":"10.13039\/501100005198","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s12072-023-10520-1","type":"journal-article","created":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T18:42:34Z","timestamp":1686076954000},"page":"1170-1181","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Exosome GLUT1 derived from hepatocyte identifies the risk of non-alcoholic steatohepatitis and fibrosis"],"prefix":"10.1007","volume":"17","author":[{"given":"Wenyan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,6]]},"reference":[{"key":"10520_CR1","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24:908\u2013922","journal-title":"Nat Med"},{"key":"10520_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73\u201384","journal-title":"Hepatology"},{"key":"10520_CR3","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.jhep.2020.06.025","volume":"73","author":"BA Davison","year":"2020","unstructured":"Davison BA, Harrison SA, Cotter G, Alkhouri N, Sanyal A, Edwards C, et al. Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials. J Hepatol. 2020;73:1322\u20131332","journal-title":"J Hepatol"},{"key":"10520_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1083\/jcb.201211138","volume":"200","author":"G Raposo","year":"2013","unstructured":"Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200:373\u2013383","journal-title":"J Cell Biol"},{"key":"10520_CR5","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.bbagen.2012.03.017","volume":"1820","author":"AV Vlassov","year":"2012","unstructured":"Vlassov AV, Magdaleno S, Setterquist R, Conrad R. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta. 2012;1820:940\u2013948","journal-title":"Biochim Biophys Acta"},{"key":"10520_CR6","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/j.biocel.2012.08.007","volume":"44","author":"C Bang","year":"2012","unstructured":"Bang C, Thum T. Exosomes: new players in cell-cell communication. Int J Biochem Cell Biol. 2012;44:2060\u20132064","journal-title":"Int J Biochem Cell Biol"},{"key":"10520_CR7","doi-asserted-by":"publisher","first-page":"6345","DOI":"10.1002\/jcp.29668","volume":"235","author":"N Jabbari","year":"2020","unstructured":"Jabbari N, Akbariazar E, Feqhhi M, Rahbarghazi R, Rezaie J. Breast cancer-derived exosomes: tumor progression and therapeutic agents. J Cell Physiol. 2020;235:6345\u20136356","journal-title":"J Cell Physiol"},{"key":"10520_CR8","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.cell.2016.01.043","volume":"164","author":"M Tkach","year":"2016","unstructured":"Tkach M, Thery C. Communication by extracellular vesicles: where we are and where we need to Go. Cell. 2016;164:1226\u20131232","journal-title":"Cell"},{"key":"10520_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/hepr.12794","volume":"47","author":"S Cai","year":"2017","unstructured":"Cai S, Cheng X, Pan X, Li J. Emerging role of exosomes in liver physiology and pathology. Hepatol Res. 2017;47:194\u2013203","journal-title":"Hepatol Res"},{"key":"10520_CR10","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1038\/s41598-017-03389-2","volume":"7","author":"YS Lee","year":"2017","unstructured":"Lee YS, Kim SY, Ko E, Lee JH, Yi HS, Yoo YJ, et al. Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells. Sci Rep. 2017;7:3710","journal-title":"Sci Rep"},{"key":"10520_CR11","volume":"11","author":"J Li","year":"2016","unstructured":"Li J, Chen X, Yi J, Liu Y, Li D, Wang J, et al. Identification and characterization of 293T cell-derived exosomes by profiling the protein, mRNA and MicroRNA components. PLoS ONE. 2016;11: e163043","journal-title":"PLoS ONE"},{"key":"10520_CR12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2217\/bmm-2017-0011","volume":"11","author":"S Wang","year":"2017","unstructured":"Wang S, Wang JQ, Lv XW. Exosomal miRNAs as biomarkers in the diagnosis of liver disease. Biomark Med. 2017;11:491\u2013501","journal-title":"Biomark Med"},{"key":"10520_CR13","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1053\/j.gastro.2016.02.064","volume":"150","author":"JM Schattenberg","year":"2016","unstructured":"Schattenberg JM, Lee MS. Extracellular vesicles as messengers between hepatocytes and macrophages in nonalcoholic steatohepatitis. Gastroenterology. 2016;150:815\u2013818","journal-title":"Gastroenterology"},{"key":"10520_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4093\/dmj.2016.40.1.1","volume":"40","author":"D Povero","year":"2016","unstructured":"Povero D, Feldstein AE. Novel molecular mechanisms in the development of non-alcoholic steatohepatitis. Diabetes Metab J. 2016;40:1\u201311","journal-title":"Diabetes Metab J"},{"key":"10520_CR15","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1053\/j.gastro.2015.12.037","volume":"150","author":"P Hirsova","year":"2016","unstructured":"Hirsova P, Ibrahim SH, Krishnan A, Verma VK, Bronk SF, Werneburg NW, et al. Lipid-induced signaling causes release of inflammatory extracellular vesicles from hepatocytes. Gastroenterology. 2016;150:956\u2013967","journal-title":"Gastroenterology"},{"key":"10520_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2019.154006","volume":"103","author":"J Wu","year":"2020","unstructured":"Wu J, Dong T, Chen T, Sun J, Luo J, He J, et al. Hepatic exosome-derived miR-130a-3p attenuates glucose intolerance via suppressing PHLPP2 gene in adipocyte. Metabolism. 2020;103: 154006","journal-title":"Metabolism"},{"key":"10520_CR17","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1002\/hep.28814","volume":"64","author":"P Hirsova","year":"2016","unstructured":"Hirsova P, Ibrahim SH, Verma VK, Morton LA, Shah VH, LaRusso NF, et al. Extracellular vesicles in liver pathobiology: small particles with big impact. Hepatology. 2016;64:2219\u20132233","journal-title":"Hepatology"},{"key":"10520_CR18","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328\u2013357","journal-title":"Hepatology"},{"key":"10520_CR19","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313\u20131321","journal-title":"Hepatology"},{"key":"10520_CR20","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43:1317\u20131325","journal-title":"Hepatology"},{"key":"10520_CR21","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45:846\u2013854","journal-title":"Hepatology"},{"key":"10520_CR22","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38:518\u2013526","journal-title":"Hepatology"},{"key":"10520_CR23","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1136\/gut.2007.146019","volume":"57","author":"SA Harrison","year":"2008","unstructured":"Harrison SA, Oliver D, Arnold HL, Gogia S, Neuschwander-Tetri BA. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut. 2008;57:1441\u20131447","journal-title":"Gut"},{"key":"10520_CR24","doi-asserted-by":"publisher","first-page":"13325","DOI":"10.1073\/pnas.1120193109","volume":"109","author":"Y Wang","year":"2012","unstructured":"Wang Y, Wang XD, Lapi E, Sullivan A, Jia W, He YW, et al. Autophagic activity dictates the cellular response to oncogenic RAS. Proc Natl Acad Sci USA. 2012;109:13325\u201313330","journal-title":"Proc Natl Acad Sci USA"},{"key":"10520_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/cells9030590","author":"D Overi","year":"2020","unstructured":"Overi D, Carpino G, Franchitto A, Onori P, Gaudio E. Hepatocyte injury and hepatic stem cell niche in the progression of non-alcoholic steatohepatitis. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9030590","journal-title":"Cells"},{"key":"10520_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9072032","author":"LA Newman","year":"2020","unstructured":"Newman LA, Sorich MJ, Rowland A. Role of extracellular vesicles in the pathophysiology, diagnosis and tracking of non-alcoholic fatty liver disease. J Clin Med. 2020. https:\/\/doi.org\/10.3390\/jcm9072032","journal-title":"J Clin Med"},{"key":"10520_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1194\/jlr.M063412","volume":"57","author":"E Kakazu","year":"2016","unstructured":"Kakazu E, Mauer AS, Yin M, Malhi H. Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1alpha-dependent manner. J Lipid Res. 2016;57:233\u2013245","journal-title":"J Lipid Res"},{"key":"10520_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrgastro.2017.71","volume":"14","author":"G Szabo","year":"2017","unstructured":"Szabo G, Momen-Heravi F. Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets. Nat Rev Gastroenterol Hepatol. 2017;14:455\u2013466","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10520_CR29","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1210\/er.2019-00034","volume":"40","author":"MJ Watt","year":"2019","unstructured":"Watt MJ, Miotto PM, De Nardo W, Montgomery MK. The liver as an endocrine organ-linking NAFLD and insulin resistance. Endocr Rev. 2019;40:1367\u20131393","journal-title":"Endocr Rev"},{"key":"10520_CR30","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.3389\/fimmu.2018.02980","volume":"9","author":"CY Liao","year":"2018","unstructured":"Liao CY, Song MJ, Gao Y, Mauer AS, Revzin A, Malhi H. Hepatocyte-derived lipotoxic extracellular vesicle sphingosine 1-phosphate induces macrophage chemotaxis. Front Immunol. 2018;9:2980","journal-title":"Front Immunol"},{"key":"10520_CR31","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.1038\/srep05237","volume":"4","author":"SE Headland","year":"2014","unstructured":"Headland SE, Jones HR, D\u2019Sa AS, Perretti M, Norling LV. Cutting-edge analysis of extracellular microparticles using ImageStream(X) imaging flow cytometry. Sci Rep. 2014;4:5237","journal-title":"Sci Rep"},{"key":"10520_CR32","doi-asserted-by":"publisher","first-page":"1587567","DOI":"10.1080\/20013078.2019.1587567","volume":"8","author":"A Gorgens","year":"2019","unstructured":"Gorgens A, Bremer M, Ferrer-Tur R, Murke F, Tertel T, Horn PA, et al. Optimisation of imaging flow cytometry for the analysis of single extracellular vesicles by using fluorescence-tagged vesicles as biological reference material. J Extracell Vesicles. 2019;8:1587567","journal-title":"J Extracell Vesicles"},{"key":"10520_CR33","doi-asserted-by":"publisher","first-page":"D1241","DOI":"10.1093\/nar\/gkr828","volume":"40","author":"S Mathivanan","year":"2012","unstructured":"Mathivanan S, Fahner CJ, Reid GE, Simpson RJ. ExoCarta 2012: database of exosomal proteins. RNA Lipids Nucleic Acids Res. 2012;40:D1241\u2013D1244","journal-title":"RNA Lipids Nucleic Acids Res"},{"key":"10520_CR34","doi-asserted-by":"publisher","first-page":"5157","DOI":"10.1021\/pr8004887","volume":"7","author":"J Conde-Vancells","year":"2008","unstructured":"Conde-Vancells J, Rodriguez-Suarez E, Embade N, Gil D, Matthiesen R, Valle M, et al. Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes. J Proteome Res. 2008;7:5157\u20135166","journal-title":"J Proteome Res"},{"key":"10520_CR35","volume":"12","author":"YE Cho","year":"2017","unstructured":"Cho YE, Im EJ, Moon PG, Mezey E, Song BJ, Baek MC. Increased liver-specific proteins in circulating extracellular vesicles as potential biomarkers for drug- and alcohol-induced liver injury. PLoS ONE. 2017;12: e172463","journal-title":"PLoS ONE"},{"issue":"4","key":"10520_CR36","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s12072-021-10217-3","volume":"15","author":"Y Jiao","year":"2021","unstructured":"Jiao Y, Lu W, Xu P, Shi H, Chen D, Chen Y, et al. Hepatocyte-derived exosome may be as a biomarker of liver regeneration and prognostic valuation in patients with acute-on-chronic liver failure. Hepatol Int. 2021;15(4):957\u2013969","journal-title":"Hepatol Int"},{"key":"10520_CR37","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1146\/annurev-biochem-060614-033904","volume":"84","author":"LQ Chen","year":"2015","unstructured":"Chen LQ, Cheung LS, Feng L, Tanner W, Frommer WB. Transport of sugars. Annu Rev Biochem. 2015;84:865\u2013894","journal-title":"Annu Rev Biochem"},{"key":"10520_CR38","doi-asserted-by":"publisher","first-page":"8530","DOI":"10.1096\/fj.201802675R","volume":"33","author":"L Wan","year":"2019","unstructured":"Wan L, Xia T, Du Y, Liu J, Xie Y, Zhang Y, et al. Exosomes from activated hepatic stellate cells contain GLUT1 and PKM2: a role for exosomes in metabolic switch of liver nonparenchymal cells. FASEB J. 2019;33:8530\u20138542","journal-title":"FASEB J"},{"key":"10520_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2022.102515","volume":"42","author":"M Yang","year":"2022","unstructured":"Yang M, Walker SA, Aguilar DDLJ, Davidovich I, Broad K, Talmon Y, et al. Extracellular vesicle glucose transporter-1 and glycan features in monocyte-endothelial inflammatory interactions. Nanomedicine. 2022;42: 102515","journal-title":"Nanomedicine"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-023-10520-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-023-10520-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-023-10520-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T17:23:38Z","timestamp":1695749018000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-023-10520-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,6]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10520"],"URL":"https:\/\/doi.org\/10.1007\/s12072-023-10520-1","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,6]]},"assertion":[{"value":"21 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Wenyan Zhang, Jing Zhang, Honglin Shi, Fang Liu, Haibin Yu, and Hongbo Shi have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}